| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 24.217 | 54.193 | 76.092 | 1.348 | 79.517 |
| Total Income - EUR | - | - | - | - | - | 24.217 | 54.193 | 76.092 | 1.348 | 79.517 |
| Total Expenses - EUR | - | - | - | - | - | 641 | 6.503 | 10.250 | 9.756 | 24.189 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 23.576 | 47.690 | 65.842 | -8.408 | 55.328 |
| Net Profit/Loss - EUR | - | - | - | - | - | 22.887 | 46.065 | 63.671 | -8.408 | 52.943 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Marad Diab Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 15.493 | 21.055 | 15.244 | 9.777 |
| Current Assets | - | - | - | - | - | 23.720 | 65.555 | 57.556 | 924 | 60.191 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 306 | 34.629 | 12.259 | 0 | 48.904 |
| Cash | - | - | - | - | - | 23.414 | 30.926 | 45.297 | 924 | 11.287 |
| Shareholders Funds | - | - | - | - | - | 22.928 | 48.439 | 63.719 | 4.224 | 52.991 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 792 | 32.609 | 14.892 | 11.944 | 16.977 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Marad Diab Med S.r.l.